ロード中...
Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial
The purpose of this study was evaluating the efficacy and safety of intravenous (IV) ampicillin–sulbactam plus nebulized colistin in the treatment of Ventilator-Associated Pneumonia (VAP) caused by MDR Acinetobacter (MDRA) in ICU patients as an alternative to IV plus nebulized colistin. In this sing...
保存先:
| 出版年: | Iran J Pharm Res |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Shaheed Beheshti University of Medical Sciences
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393051/ https://ncbi.nlm.nih.gov/pubmed/32802106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2019.112466.13775 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|